233 related articles for article (PubMed ID: 23382994)
1. Neurotrophic and neuroprotective actions of (-)- and (+)-phenserine, candidate drugs for Alzheimer's disease.
Lilja AM; Luo Y; Yu QS; Röjdner J; Li Y; Marini AM; Marutle A; Nordberg A; Greig NH
PLoS One; 2013; 8(1):e54887. PubMed ID: 23382994
[TBL] [Abstract][Full Text] [Related]
2. The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice.
Lahiri DK; Chen D; Maloney B; Holloway HW; Yu QS; Utsuki T; Giordano T; Sambamurti K; Greig NH
J Pharmacol Exp Ther; 2007 Jan; 320(1):386-96. PubMed ID: 17003227
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent neuroplasticity mechanisms in Alzheimer Tg2576 mice following modulation of brain amyloid-β levels.
Lilja AM; Röjdner J; Mustafiz T; Thomé CM; Storelli E; Gonzalez D; Unger-Lithner C; Greig NH; Nordberg A; Marutle A
PLoS One; 2013; 8(3):e58752. PubMed ID: 23554921
[TBL] [Abstract][Full Text] [Related]
4. (-)-Phenserine inhibits neuronal apoptosis following ischemia/reperfusion injury.
Chang CF; Lai JH; Wu JC; Greig NH; Becker RE; Luo Y; Chen YH; Kang SJ; Chiang YH; Chen KY
Brain Res; 2017 Dec; 1677():118-128. PubMed ID: 28963051
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel small molecule inhibitors of amyloid precursor protein synthesis as a route to lower Alzheimer's disease amyloid-beta peptide.
Utsuki T; Yu QS; Davidson D; Chen D; Holloway HW; Brossi A; Sambamurti K; Lahiri DK; Greig NH; Giordano T
J Pharmacol Exp Ther; 2006 Aug; 318(2):855-62. PubMed ID: 16690718
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of the Alzheimer drug Posiphen into its primary metabolic products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their inhibition of amyloid precursor protein, α-Synuclein synthesis, interleukin-1β release, and cholinergic action.
Yu QS; Reale M; Kamal MA; Holloway HW; Luo W; Sambamurti K; Ray B; Lahiri DK; Rogers JT; Greig NH
Antiinflamm Antiallergy Agents Med Chem; 2013; 12(2):117-28. PubMed ID: 23360256
[TBL] [Abstract][Full Text] [Related]
7. Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine.
Marutle A; Ohmitsu M; Nilbratt M; Greig NH; Nordberg A; Sugaya K
Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12506-11. PubMed ID: 17640880
[TBL] [Abstract][Full Text] [Related]
8. Phenserine.
Klein J
Expert Opin Investig Drugs; 2007 Jul; 16(7):1087-97. PubMed ID: 17594192
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of two hexahydropyrroloindole carbamate-based anticholinesterase drugs on the amyloid beta protein pathway involved in Alzheimer's disease.
Lahiri DK; Alley GM; Tweedie D; Chen D; Greig NH
Neuromolecular Med; 2007; 9(2):157-68. PubMed ID: 17627035
[TBL] [Abstract][Full Text] [Related]
10. Neural Stem Cell Transplant-Induced Effect on Neurogenesis and Cognition in Alzheimer Tg2576 Mice Is Inhibited by Concomitant Treatment with Amyloid-Lowering or Cholinergic α7 Nicotinic Receptor Drugs.
Lilja AM; Malmsten L; Röjdner J; Voytenko L; Verkhratsky A; Ögren SO; Nordberg A; Marutle A
Neural Plast; 2015; 2015():370432. PubMed ID: 26257960
[TBL] [Abstract][Full Text] [Related]
11. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
[TBL] [Abstract][Full Text] [Related]
12. Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development.
Shaw KT; Utsuki T; Rogers J; Yu QS; Sambamurti K; Brossi A; Ge YW; Lahiri DK; Greig NH
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7605-10. PubMed ID: 11404470
[TBL] [Abstract][Full Text] [Related]
13. (-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer's disease challenged mice.
Lecca D; Bader M; Tweedie D; Hoffman AF; Jung YJ; Hsueh SC; Hoffer BJ; Becker RE; Pick CG; Lupica CR; Greig NH
Neurobiol Dis; 2019 Oct; 130():104528. PubMed ID: 31295555
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron.
Perry T; Lahiri DK; Sambamurti K; Chen D; Mattson MP; Egan JM; Greig NH
J Neurosci Res; 2003 Jun; 72(5):603-12. PubMed ID: 12749025
[TBL] [Abstract][Full Text] [Related]
15. The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region.
Venti A; Giordano T; Eder P; Bush AI; Lahiri DK; Greig NH; Rogers JT
Ann N Y Acad Sci; 2004 Dec; 1035():34-48. PubMed ID: 15681799
[TBL] [Abstract][Full Text] [Related]
16. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
17. Cognitive Impairments Induced by Concussive Mild Traumatic Brain Injury in Mouse Are Ameliorated by Treatment with Phenserine via Multiple Non-Cholinergic and Cholinergic Mechanisms.
Tweedie D; Fukui K; Li Y; Yu QS; Barak S; Tamargo IA; Rubovitch V; Holloway HW; Lehrmann E; Wood WH; Zhang Y; Becker KG; Perez E; Van Praag H; Luo Y; Hoffer BJ; Becker RE; Pick CG; Greig NH
PLoS One; 2016; 11(6):e0156493. PubMed ID: 27254111
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
19. Shenzao jiannao oral liquid, an herbal formula, ameliorates cognitive impairments by rescuing neuronal death and triggering endogenous neurogenesis in AD-like mice induced by a combination of Aβ42 and scopolamine.
Xiao H; Li H; Song H; Kong L; Yan X; Li Y; Deng Y; Tai H; Wu Y; Ni Y; Li W; Chen J; Yang J
J Ethnopharmacol; 2020 Sep; 259():112957. PubMed ID: 32416248
[TBL] [Abstract][Full Text] [Related]
20. An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease.
Greig NH; Sambamurti K; Yu QS; Brossi A; Bruinsma GB; Lahiri DK
Curr Alzheimer Res; 2005 Jul; 2(3):281-90. PubMed ID: 15974893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
